Depression and Anxiety Trial, Not Yet Recruiting NCT07545928 Sponsor: University Hospital, Strasbourg, France Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT07545928
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older who are currently admitted to the USP - HUS hospital.
  • People with an estimated life expectancy of at least 1 month, as assessed using a specific clinical scoring tool called the Pronopall score.
  • People who score 26 or above on a standard memory and thinking assessment called the Montreal Cognitive Assessment (MoCA).
  • People who are able to understand the purpose and risks of the study.
  • People who score 25 or below on a motion sickness and comfort assessment (called the VRISE score) after a short introductory session with virtual reality equipment.
  • People who are affiliated with or covered by the French Social Security system.
  • People who have signed a consent form and are able to understand and complete questionnaires written in French.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a psychiatric illness or condition.
  • People who are under court-ordered legal protection (confirm with trial site).
  • People who have epilepsy that is not well controlled.
  • People who have vision problems (such as being unable to use both eyes together, or being blind) or hearing problems (such as deafness) that would prevent them from using virtual reality equipment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33(0)6.28.07.12.74

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Feasibility Success : Adherence; Feasibility Success : Duration; Feasibility Success : Safety; Feasibility Success : Tolerance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov